Surgalign Holdings Inc
XBER:RT2
Gross Margin
Surgalign Holdings Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
S
|
Surgalign Holdings Inc
F:RT2
|
20.1m EUR |
47%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
6.2T JPY |
86%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
35.1B CHF |
54%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
141.9B DKK |
68%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.6B USD |
70%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.9B GBP |
57%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
45.5B CNY |
70%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
5.2B CHF |
35%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.6B USD |
48%
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.1B USD |
64%
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7T KRW |
20%
|
Surgalign Holdings Inc
Glance View
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Surgalign Holdings Inc's most recent financial statements, the company has Gross Margin of 47.1%.
You don't have any saved screeners yet